Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Standard Biotools (LAB) Current Taxes (2022 - 2023)

Standard Biotools (LAB) has disclosed Current Taxes for 1 consecutive years, with $1.4 million as the latest value for Q4 2022.

On a quarterly basis, Current Taxes changed N/A to $1.4 million in Q4 2022 year-over-year; TTM through Dec 2022 was $1.4 million, a N/A change, with the full-year FY2022 number at $1.4 million, changed N/A from a year prior.
Current Taxes was $1.4 million for Q4 2022 at Standard Biotools.
In the past five years, Current Taxes ranged from a high of $1.4 million in Q4 2022 to a low of $1.4 million in Q4 2022.